PLGA微球,PLGA microspheres
1)PLGA microspheresPLGA微球
1.Preparation and property of bupivacaine hydrochloride PLGA microspheres for local anesthesia;局部麻醉用缓释盐酸布比卡因PLGA微球的制备及特性研究
2.Objective This paper focused on adjusting the release rates of risperidone from PLGA microspheres by co-encapsulating Mg(OH)2.目的用氢氧化镁调节利培酮PLGA微球的释放速度。
3.In this study,poly(lactic-co-glycolic acid )(PLGA) is used as a kind of relatively ideal carrier of drug controlled delivery to prepare the bFGF-PLGA microspheres which contain bFGF as the model drug,by the method of water in oil in water(w_1/o/w_2).采用体外释放实验来验证PLGA微球作为bFGF控制释放载体的可行性。
英文短句/例句

1.Research on Sustained Releasable Chitosan Scaffolds with PLGA Microspheres EmbeddedPLGA微球在壳聚糖支架内的缓释研究
2.Influence of different downstream processes on separation of PLGA microparticles下游处理对PLGA微球分离制备的影响
3.Preparation of Uniform Size PLGA Microparticles and Microcapsules by Premix Membrane Emulsification快速膜乳化法制备粒径均一的PLGA微球和微囊
4.Preparation and Lung-targeting Evaluation of PLGA Microspheres Loaded with Anticancer Yuanhuacine;抗癌药物芫花酯甲PLGA微球制备与肺靶向性评价
5.Pharmacokinetics and Pharmacodynamics of Poly(Lactide-co-glycolide) Microspheres Containing Ropivacaine after Subcutaneous Administration in Rabbits罗哌卡因PLGA微球兔皮下给药的药效学和药动学
6.Influence Factors on Preparation of Protein Drugs Loaded PLGA Microspheres by Double Emulsion Method:A Review复乳法制备蛋白质药物PLGA微球的影响因素
7.The Release Study in Vitro of PLGA Microparticles Enwrapping Photosensitizer m-THPC包裹光敏剂m-THPC的PLGA微球的体外释放特性研究
8.Intratumoral Delivery of Paclitaxel-loaded PLGA Microspheres in Nude Mice Bearing Laryngeal Squamous Cell Carcinoma Xenografts;紫杉醇PLGA微球瘤内注射治疗喉癌裸鼠移植瘤的实验研究
9.The Inhibiting Effect of Triamcinolone-PLGA-Ms on Raw Surface of Rabbit Palate Was Empirical Studied;曲安奈德PLGA微球对兔上腭部创面瘢痕愈合作用的实验研究
10.Experimental Study on Preparation of GM-1 PLGA Microspheres and Therapy of Rat SCI Model;GM-1 PLGA微球的制备及治疗大鼠脊髓损伤的实验研究
11.Experimental Study on Preparation of MPS-PLGA Microspheres and Therapy of Rat SCI Model;MPS-PLGA微球的制备及其治疗大鼠脊髓压迫损伤的实验研究
12.Studies on Ajuvants of Poly (D, L-Lactide-Co-Glycolide) Microspheres;聚乳酸聚乙醇酸(PLGA)微球佐剂的研究
13.Research Progress on PLGA Nanoparticles/Microspheres as DNA CarriersPLGA纳米/微球作为核酸载体的研究进展
14.Optimization of preparation of BSA-PLGA controlled-release microspheresBSA-PLGA缓释微球制备工艺的优化
15.Acute Toxicity Study of PLGA-Oxaliplatin MicrospherePLGA-奥沙利铂缓释微球急性毒性实验
16.Studies on IFN-α-2b Loaded Sustained-release PLGA Microspheres with Nonaqueous Method;无水法制备干扰素-α-2b PLGA缓释微球的研究
17.Study on Sustained Release PLGA Microsphere with Biodegradation of Gatifloxacin加替沙星PLGA生物可降解缓释微球的研究
18.Poly(Hydroxybutyrate-Hydroxyvalerate)-Poly(Lactide-co-Glycolide) Sustained-Release Microspheres Entrapping Gentamicin Sulfate以PHBV-PLGA为载体的硫酸庆大霉素缓释微球
相关短句/例句

PLGA microspherePLGA微球
1.Preparation and release behavior of chitosan scaffolds encapsulating proteins loaded in PLGA microspheres;包埋PLGA微球壳聚糖支架的构建及其对蛋白释放的调节
2.Preparation and in vitro release behavior of the gentamicin sulfate-encapsulated PLGA microspheres;硫酸庆大霉素/PLGA微球具有显著的药物缓释作用,体外释放30d的累积释药率达80%以上。
3)Liposome-encapsulated vaccinePLGA微球疫苗
4)intereron α-2b PLGA microspheres干扰素α-2b PLGA微球
1.OBJECTIVE To develop an enzyme linked immunosorbent assay(ELISA) method for the content determination of intereron α-2b PLGA microspheres in the serum of rats and study the pharmacokinetics and bioavailability of in rats after subcutaneous administration.结论ELISA法灵敏度高、重复性好,可作为干扰素α-2b PLGA微球临床前药动学的检测方法;干扰素α-2b PLGA微球具有明显的缓释作用,显著提高了干扰素α-2b的生物利用度。
5)PLGA microparticlesPLGA微囊
1.The DCs were pulsed and chased with OVA encapsulated in PLGA microparticles and then fixed before the addition of OVA\|specific DO11·GFP T hybridom cells to analyse the degree of antigen presentation.本研究在体外将含卵清蛋白 (OVA)的PLGA微囊与小鼠骨髓诱导的树突细胞 (BM DC)相互作用 ,然后用卵清蛋白特异性杂交瘤T细胞检测OVA抗原在BM DC表面的表达 ,结果显示 :PLGA微囊可以在体外显著促进BM DC对OVA抗原的呈递。
6)poly lactic-glycotic acid/hydroxyapatite(PLGA/HA)PLGA/HA
延伸阅读

可降解淀粉微球和生物降解白蛋白微球阻滞法可降解淀粉微球和生物降解白蛋白微球阻滞法 介入放射学技术。介入性局部化疗之前,把二者注入靶动脉,可暂时减少动脉血流,再行化疗药物灌注,以减少血液冲刷,保持局部化疗药物浓度的技术。与其他中期和长期栓塞微球不同,DSM和BAM仅造成数十分钟的血流量减少,待其被降解后血流可恢复至以前水平。